nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—DPP4—rheumatoid arthritis	0.843	1	CbGaD
Vidarabine—DPP4—exocrine gland—rheumatoid arthritis	0.00321	0.135	CbGeAlD
Vidarabine—ADA—connective tissue—rheumatoid arthritis	0.00186	0.0784	CbGeAlD
Vidarabine—ADK—parotid gland—rheumatoid arthritis	0.00172	0.0728	CbGeAlD
Vidarabine—DPP4—parotid gland—rheumatoid arthritis	0.00167	0.0705	CbGeAlD
Vidarabine—ADK—saliva-secreting gland—rheumatoid arthritis	0.00165	0.0697	CbGeAlD
Vidarabine—DPP4—saliva-secreting gland—rheumatoid arthritis	0.0016	0.0676	CbGeAlD
Vidarabine—DPP4—connective tissue—rheumatoid arthritis	0.00147	0.0621	CbGeAlD
Vidarabine—ADA—lymphoid tissue—rheumatoid arthritis	0.00136	0.0573	CbGeAlD
Vidarabine—ADA—digestive system—rheumatoid arthritis	0.00134	0.0566	CbGeAlD
Vidarabine—Glucosamine—IFNG—rheumatoid arthritis	0.00132	0.272	CrCbGaD
Vidarabine—ADA—tendon—rheumatoid arthritis	0.00128	0.0539	CbGeAlD
Vidarabine—ADORA2A—lymphoid tissue—rheumatoid arthritis	0.00123	0.0521	CbGeAlD
Vidarabine—ADK—lymphoid tissue—rheumatoid arthritis	0.00111	0.0468	CbGeAlD
Vidarabine—Adenosine triphosphate—ADRBK1—rheumatoid arthritis	0.00109	0.225	CrCbGaD
Vidarabine—DPP4—lymphoid tissue—rheumatoid arthritis	0.00108	0.0454	CbGeAlD
Vidarabine—DPP4—digestive system—rheumatoid arthritis	0.00106	0.0448	CbGeAlD
Vidarabine—Adenosine—DPP4—rheumatoid arthritis	0.00105	0.216	CrCbGaD
Vidarabine—ADK—tendon—rheumatoid arthritis	0.00104	0.044	CbGeAlD
Vidarabine—DPP4—tendon—rheumatoid arthritis	0.00101	0.0427	CbGeAlD
Vidarabine—Glucosamine—MMP9—rheumatoid arthritis	0.000843	0.173	CrCbGaD
Vidarabine—Glucosamine—TNF—rheumatoid arthritis	0.000554	0.114	CrCbGaD
Vidarabine—ADA—Nucleotide metabolism—CAT—rheumatoid arthritis	0.00043	0.0105	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—LEP—rheumatoid arthritis	0.000374	0.0091	CbGpPWpGaD
Vidarabine—ADA—p73 transcription factor network—FAS—rheumatoid arthritis	0.00036	0.00877	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—EDEM3—rheumatoid arthritis	0.000355	0.00866	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—AHR—rheumatoid arthritis	0.000352	0.00858	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—ST6GALNAC5—rheumatoid arthritis	0.000334	0.00814	CbGpPWpGaD
Vidarabine—DPP4—Peptide hormone metabolism—POMC—rheumatoid arthritis	0.000321	0.00782	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—SYVN1—rheumatoid arthritis	0.000302	0.00736	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—KIF5A—rheumatoid arthritis	0.000302	0.00736	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL6—rheumatoid arthritis	0.000283	0.0069	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL21—rheumatoid arthritis	0.00027	0.00658	CbGpPWpGaD
Vidarabine—ADK—Metabolism—FADS2—rheumatoid arthritis	0.000264	0.00644	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—SLC25A12—rheumatoid arthritis	0.000253	0.00617	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—ADIPOQ—rheumatoid arthritis	0.000252	0.00614	CbGpPWpGaD
Vidarabine—ADORA2A—Monoamine Transport—IL1B—rheumatoid arthritis	0.000249	0.00607	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—CD4—rheumatoid arthritis	0.000217	0.00529	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.000216	0.00525	CbGpPWpGaD
Vidarabine—ADA—C-MYB transcription factor network—PTGS2—rheumatoid arthritis	0.000216	0.00525	CbGpPWpGaD
Vidarabine—Angioedema—Cyclosporine—rheumatoid arthritis	0.000208	0.00238	CcSEcCtD
Vidarabine—Arrhythmia—Hydrocortisone—rheumatoid arthritis	0.000208	0.00238	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL21—rheumatoid arthritis	0.000206	0.00501	CbGpPWpGaD
Vidarabine—Pain—Leflunomide—rheumatoid arthritis	0.000206	0.00236	CcSEcCtD
Vidarabine—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.000203	0.00232	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—AHR—rheumatoid arthritis	0.000202	0.00493	CbGpPWpGaD
Vidarabine—Bradycardia—Dexamethasone—rheumatoid arthritis	0.000202	0.00231	CcSEcCtD
Vidarabine—Bradycardia—Betamethasone—rheumatoid arthritis	0.000202	0.00231	CcSEcCtD
Vidarabine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—rheumatoid arthritis	0.000201	0.0049	CbGpPWpGaD
Vidarabine—Cough—Cyclosporine—rheumatoid arthritis	0.000199	0.00227	CcSEcCtD
Vidarabine—Mood swings—Methotrexate—rheumatoid arthritis	0.000198	0.00227	CcSEcCtD
Vidarabine—Convulsion—Cyclosporine—rheumatoid arthritis	0.000197	0.00226	CcSEcCtD
Vidarabine—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.000197	0.00225	CcSEcCtD
Vidarabine—Hypertension—Cyclosporine—rheumatoid arthritis	0.000196	0.00225	CcSEcCtD
Vidarabine—Arrhythmia—Triamcinolone—rheumatoid arthritis	0.000195	0.00224	CcSEcCtD
Vidarabine—Vision blurred—Prednisolone—rheumatoid arthritis	0.000195	0.00224	CcSEcCtD
Vidarabine—Arrhythmia—Methylprednisolone—rheumatoid arthritis	0.000195	0.00223	CcSEcCtD
Vidarabine—Chest pain—Cyclosporine—rheumatoid arthritis	0.000194	0.00222	CcSEcCtD
Vidarabine—Anxiety—Cyclosporine—rheumatoid arthritis	0.000193	0.00221	CcSEcCtD
Vidarabine—Discomfort—Cyclosporine—rheumatoid arthritis	0.000191	0.00219	CcSEcCtD
Vidarabine—Urticaria—Leflunomide—rheumatoid arthritis	0.000191	0.00219	CcSEcCtD
Vidarabine—Acute coronary syndrome—Prednisone—rheumatoid arthritis	0.00019	0.00217	CcSEcCtD
Vidarabine—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000189	0.00217	CcSEcCtD
Vidarabine—Angioedema—Prednisolone—rheumatoid arthritis	0.000189	0.00217	CcSEcCtD
Vidarabine—Myocardial infarction—Prednisone—rheumatoid arthritis	0.000189	0.00216	CcSEcCtD
Vidarabine—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000188	0.00215	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—B3GNT2—rheumatoid arthritis	0.000187	0.00455	CbGpPWpGaD
Vidarabine—Dysgeusia—Triamcinolone—rheumatoid arthritis	0.000186	0.00214	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Other—CCR5—rheumatoid arthritis	0.000186	0.00454	CbGpPWpGaD
Vidarabine—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.000186	0.00213	CcSEcCtD
Vidarabine—Syncope—Prednisolone—rheumatoid arthritis	0.000186	0.00213	CcSEcCtD
Vidarabine—Angioedema—Hydrocortisone—rheumatoid arthritis	0.000185	0.00212	CcSEcCtD
Vidarabine—Back pain—Triamcinolone—rheumatoid arthritis	0.000184	0.00211	CcSEcCtD
Vidarabine—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.000182	0.00208	CcSEcCtD
Vidarabine—Syncope—Hydrocortisone—rheumatoid arthritis	0.000181	0.00208	CcSEcCtD
Vidarabine—ADORA2A—Monoamine Transport—TNF—rheumatoid arthritis	0.000181	0.0044	CbGpPWpGaD
Vidarabine—ADA—Metabolism—FADS2—rheumatoid arthritis	0.00018	0.00438	CbGpPWpGaD
Vidarabine—Hyperhidrosis—Cyclosporine—rheumatoid arthritis	0.00018	0.00206	CcSEcCtD
Vidarabine—Convulsion—Prednisolone—rheumatoid arthritis	0.000179	0.00205	CcSEcCtD
Vidarabine—Hypertension—Prednisolone—rheumatoid arthritis	0.000179	0.00205	CcSEcCtD
Vidarabine—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.000178	0.00204	CcSEcCtD
Vidarabine—Arrhythmia—Dexamethasone—rheumatoid arthritis	0.000177	0.00203	CcSEcCtD
Vidarabine—Arrhythmia—Betamethasone—rheumatoid arthritis	0.000177	0.00203	CcSEcCtD
Vidarabine—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000177	0.00203	CcSEcCtD
Vidarabine—ADK—Metabolism—PLD4—rheumatoid arthritis	0.000176	0.0043	CbGpPWpGaD
Vidarabine—Bradycardia—Prednisone—rheumatoid arthritis	0.000176	0.00202	CcSEcCtD
Vidarabine—Convulsion—Hydrocortisone—rheumatoid arthritis	0.000175	0.00201	CcSEcCtD
Vidarabine—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000175	0.002	CcSEcCtD
Vidarabine—Discomfort—Prednisolone—rheumatoid arthritis	0.000174	0.00199	CcSEcCtD
Vidarabine—Angioedema—Triamcinolone—rheumatoid arthritis	0.000174	0.00199	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.000174	0.00423	CbGpPWpGaD
Vidarabine—Angioedema—Methylprednisolone—rheumatoid arthritis	0.000174	0.00199	CcSEcCtD
Vidarabine—Abdominal discomfort—Methotrexate—rheumatoid arthritis	0.000173	0.00198	CcSEcCtD
Vidarabine—Asthenia—Leflunomide—rheumatoid arthritis	0.000173	0.00198	CcSEcCtD
Vidarabine—Anxiety—Hydrocortisone—rheumatoid arthritis	0.000172	0.00197	CcSEcCtD
Vidarabine—Syncope—Triamcinolone—rheumatoid arthritis	0.000171	0.00196	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—FAS—rheumatoid arthritis	0.000171	0.00415	CbGpPWpGaD
Vidarabine—Syncope—Methylprednisolone—rheumatoid arthritis	0.00017	0.00195	CcSEcCtD
Vidarabine—ADK—Metabolism—ACAN—rheumatoid arthritis	0.00017	0.00415	CbGpPWpGaD
Vidarabine—Discomfort—Hydrocortisone—rheumatoid arthritis	0.00017	0.00195	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000169	0.00194	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.000169	0.00194	CcSEcCtD
Vidarabine—Dizziness—Azathioprine—rheumatoid arthritis	0.000169	0.00193	CcSEcCtD
Vidarabine—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.000167	0.00192	CcSEcCtD
Vidarabine—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.000167	0.00191	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.000167	0.00407	CbGpPWpGaD
Vidarabine—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000167	0.00191	CcSEcCtD
Vidarabine—Shock—Prednisolone—rheumatoid arthritis	0.000166	0.0019	CcSEcCtD
Vidarabine—Cough—Triamcinolone—rheumatoid arthritis	0.000166	0.0019	CcSEcCtD
Vidarabine—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000166	0.0019	CcSEcCtD
Vidarabine—Somnolence—Cyclosporine—rheumatoid arthritis	0.000165	0.00189	CcSEcCtD
Vidarabine—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.000165	0.00189	CcSEcCtD
Vidarabine—Convulsion—Triamcinolone—rheumatoid arthritis	0.000165	0.00189	CcSEcCtD
Vidarabine—Tachycardia—Prednisolone—rheumatoid arthritis	0.000165	0.00189	CcSEcCtD
Vidarabine—Convulsion—Methylprednisolone—rheumatoid arthritis	0.000165	0.00189	CcSEcCtD
Vidarabine—Hypertension—Triamcinolone—rheumatoid arthritis	0.000164	0.00188	CcSEcCtD
Vidarabine—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000164	0.00188	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisolone—rheumatoid arthritis	0.000163	0.00187	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—HSPD1—rheumatoid arthritis	0.000163	0.00398	CbGpPWpGaD
Vidarabine—Shock—Hydrocortisone—rheumatoid arthritis	0.000162	0.00186	CcSEcCtD
Vidarabine—Vomiting—Azathioprine—rheumatoid arthritis	0.000162	0.00186	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—IRAK1—rheumatoid arthritis	0.000162	0.00394	CbGpPWpGaD
Vidarabine—Anxiety—Methylprednisolone—rheumatoid arthritis	0.000161	0.00185	CcSEcCtD
Vidarabine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000161	0.00185	CcSEcCtD
Vidarabine—Drowsiness—Methotrexate—rheumatoid arthritis	0.000161	0.00184	CcSEcCtD
Vidarabine—Rash—Azathioprine—rheumatoid arthritis	0.000161	0.00184	CcSEcCtD
Vidarabine—Dermatitis—Azathioprine—rheumatoid arthritis	0.000161	0.00184	CcSEcCtD
Vidarabine—Flushing—Prednisone—rheumatoid arthritis	0.00016	0.00184	CcSEcCtD
Vidarabine—Discomfort—Triamcinolone—rheumatoid arthritis	0.00016	0.00183	CcSEcCtD
Vidarabine—ADK—Metabolism—SLC25A12—rheumatoid arthritis	0.00016	0.0039	CbGpPWpGaD
Vidarabine—Discomfort—Methylprednisolone—rheumatoid arthritis	0.00016	0.00183	CcSEcCtD
Vidarabine—Headache—Azathioprine—rheumatoid arthritis	0.00016	0.00183	CcSEcCtD
Vidarabine—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	0.00016	0.00183	CcSEcCtD
Vidarabine—Dizziness—Leflunomide—rheumatoid arthritis	0.000159	0.00182	CcSEcCtD
Vidarabine—Pain—Cyclosporine—rheumatoid arthritis	0.000159	0.00182	CcSEcCtD
Vidarabine—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000159	0.00182	CcSEcCtD
Vidarabine—Angioedema—Betamethasone—rheumatoid arthritis	0.000158	0.00181	CcSEcCtD
Vidarabine—Angioedema—Dexamethasone—rheumatoid arthritis	0.000158	0.00181	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—LEP—rheumatoid arthritis	0.000157	0.00381	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGES—rheumatoid arthritis	0.000156	0.00379	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GC—rheumatoid arthritis	0.000156	0.00379	CbGpPWpGaD
Vidarabine—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000155	0.00178	CcSEcCtD
Vidarabine—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000155	0.00178	CcSEcCtD
Vidarabine—Syncope—Betamethasone—rheumatoid arthritis	0.000155	0.00177	CcSEcCtD
Vidarabine—Syncope—Dexamethasone—rheumatoid arthritis	0.000155	0.00177	CcSEcCtD
Vidarabine—Arrhythmia—Prednisone—rheumatoid arthritis	0.000154	0.00177	CcSEcCtD
Vidarabine—Sweating—Methotrexate—rheumatoid arthritis	0.000154	0.00177	CcSEcCtD
Vidarabine—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000154	0.00177	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD28—rheumatoid arthritis	0.000153	0.00373	CbGpPWpGaD
Vidarabine—Vomiting—Leflunomide—rheumatoid arthritis	0.000153	0.00175	CcSEcCtD
Vidarabine—Shock—Triamcinolone—rheumatoid arthritis	0.000153	0.00175	CcSEcCtD
Vidarabine—Shock—Methylprednisolone—rheumatoid arthritis	0.000153	0.00175	CcSEcCtD
Vidarabine—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000152	0.00174	CcSEcCtD
Vidarabine—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000152	0.00174	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.000152	0.0037	CbGpPWpGaD
Vidarabine—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000152	0.00174	CcSEcCtD
Vidarabine—Rash—Leflunomide—rheumatoid arthritis	0.000152	0.00174	CcSEcCtD
Vidarabine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000152	0.00174	CcSEcCtD
Vidarabine—Dermatitis—Leflunomide—rheumatoid arthritis	0.000152	0.00174	CcSEcCtD
Vidarabine—Nausea—Azathioprine—rheumatoid arthritis	0.000151	0.00173	CcSEcCtD
Vidarabine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000151	0.00173	CcSEcCtD
Vidarabine—Headache—Leflunomide—rheumatoid arthritis	0.000151	0.00173	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.00015	0.00172	CcSEcCtD
Vidarabine—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.00015	0.00172	CcSEcCtD
Vidarabine—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.00015	0.00172	CcSEcCtD
Vidarabine—Convulsion—Dexamethasone—rheumatoid arthritis	0.00015	0.00171	CcSEcCtD
Vidarabine—Convulsion—Betamethasone—rheumatoid arthritis	0.00015	0.00171	CcSEcCtD
Vidarabine—Hypertension—Dexamethasone—rheumatoid arthritis	0.000149	0.00171	CcSEcCtD
Vidarabine—Hypertension—Betamethasone—rheumatoid arthritis	0.000149	0.00171	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.000149	0.00362	CbGpPWpGaD
Vidarabine—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000148	0.0017	CcSEcCtD
Vidarabine—Urticaria—Cyclosporine—rheumatoid arthritis	0.000148	0.00169	CcSEcCtD
Vidarabine—Anxiety—Dexamethasone—rheumatoid arthritis	0.000147	0.00168	CcSEcCtD
Vidarabine—Anxiety—Betamethasone—rheumatoid arthritis	0.000147	0.00168	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—NOS2—rheumatoid arthritis	0.000146	0.00355	CbGpPWpGaD
Vidarabine—Discomfort—Dexamethasone—rheumatoid arthritis	0.000145	0.00166	CcSEcCtD
Vidarabine—Discomfort—Betamethasone—rheumatoid arthritis	0.000145	0.00166	CcSEcCtD
Vidarabine—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000145	0.00166	CcSEcCtD
Vidarabine—ADK—Metabolism—PLB1—rheumatoid arthritis	0.000145	0.00353	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—ADIPOQ—rheumatoid arthritis	0.000145	0.00352	CbGpPWpGaD
Vidarabine—Pain—Prednisolone—rheumatoid arthritis	0.000145	0.00166	CcSEcCtD
Vidarabine—Nausea—Leflunomide—rheumatoid arthritis	0.000143	0.00164	CcSEcCtD
Vidarabine—Vision blurred—Prednisone—rheumatoid arthritis	0.000142	0.00162	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000142	0.00162	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000141	0.00162	CcSEcCtD
Vidarabine—Pain—Hydrocortisone—rheumatoid arthritis	0.000141	0.00162	CcSEcCtD
Vidarabine—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000141	0.00162	CcSEcCtD
Vidarabine—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000141	0.00162	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ADRBK1—rheumatoid arthritis	0.00014	0.0034	CbGpPWpGaD
Vidarabine—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.00014	0.0016	CcSEcCtD
Vidarabine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000139	0.00159	CcSEcCtD
Vidarabine—Shock—Dexamethasone—rheumatoid arthritis	0.000139	0.00159	CcSEcCtD
Vidarabine—Shock—Betamethasone—rheumatoid arthritis	0.000139	0.00159	CcSEcCtD
Vidarabine—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000139	0.00159	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.000138	0.00337	CbGpPWpGaD
Vidarabine—Agitation—Prednisone—rheumatoid arthritis	0.000138	0.00158	CcSEcCtD
Vidarabine—Tachycardia—Betamethasone—rheumatoid arthritis	0.000138	0.00158	CcSEcCtD
Vidarabine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000138	0.00158	CcSEcCtD
Vidarabine—Angioedema—Prednisone—rheumatoid arthritis	0.000137	0.00157	CcSEcCtD
Vidarabine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000137	0.00157	CcSEcCtD
Vidarabine—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000136	0.00156	CcSEcCtD
Vidarabine—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000136	0.00156	CcSEcCtD
Vidarabine—Syncope—Prednisone—rheumatoid arthritis	0.000135	0.00155	CcSEcCtD
Vidarabine—Tinnitus—Methotrexate—rheumatoid arthritis	0.000135	0.00154	CcSEcCtD
Vidarabine—Urticaria—Prednisolone—rheumatoid arthritis	0.000134	0.00154	CcSEcCtD
Vidarabine—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000134	0.00154	CcSEcCtD
Vidarabine—Asthenia—Cyclosporine—rheumatoid arthritis	0.000133	0.00153	CcSEcCtD
Vidarabine—Pain—Triamcinolone—rheumatoid arthritis	0.000133	0.00152	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—TRAF6—rheumatoid arthritis	0.000133	0.00323	CbGpPWpGaD
Vidarabine—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000132	0.00151	CcSEcCtD
Vidarabine—Hypotension—Dexamethasone—rheumatoid arthritis	0.000132	0.00151	CcSEcCtD
Vidarabine—Hypotension—Betamethasone—rheumatoid arthritis	0.000132	0.00151	CcSEcCtD
Vidarabine—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000131	0.0015	CcSEcCtD
Vidarabine—Convulsion—Prednisone—rheumatoid arthritis	0.00013	0.00149	CcSEcCtD
Vidarabine—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.00013	0.00149	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.00013	0.00317	CbGpPWpGaD
Vidarabine—Hypertension—Prednisone—rheumatoid arthritis	0.00013	0.00149	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000128	0.00147	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000128	0.00147	CcSEcCtD
Vidarabine—Anxiety—Prednisone—rheumatoid arthritis	0.000128	0.00146	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—CTSD—rheumatoid arthritis	0.000127	0.0031	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.000127	0.0031	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MED1—rheumatoid arthritis	0.000127	0.00309	CbGpPWpGaD
Vidarabine—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000127	0.00145	CcSEcCtD
Vidarabine—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000127	0.00145	CcSEcCtD
Vidarabine—Discomfort—Prednisone—rheumatoid arthritis	0.000127	0.00145	CcSEcCtD
Vidarabine—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000125	0.00143	CcSEcCtD
Vidarabine—Urticaria—Triamcinolone—rheumatoid arthritis	0.000123	0.00141	CcSEcCtD
Vidarabine—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000123	0.00141	CcSEcCtD
Vidarabine—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000123	0.00141	CcSEcCtD
Vidarabine—Dizziness—Cyclosporine—rheumatoid arthritis	0.000123	0.00141	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000123	0.00141	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.000122	0.00297	CbGpPWpGaD
Vidarabine—Back pain—Methotrexate—rheumatoid arthritis	0.000122	0.00139	CcSEcCtD
Vidarabine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000122	0.00139	CcSEcCtD
Vidarabine—Shock—Prednisone—rheumatoid arthritis	0.000121	0.00138	CcSEcCtD
Vidarabine—Pain—Dexamethasone—rheumatoid arthritis	0.000121	0.00138	CcSEcCtD
Vidarabine—Pain—Betamethasone—rheumatoid arthritis	0.000121	0.00138	CcSEcCtD
Vidarabine—ADA—Metabolism—PLD4—rheumatoid arthritis	0.00012	0.00292	CbGpPWpGaD
Vidarabine—Tachycardia—Prednisone—rheumatoid arthritis	0.00012	0.00137	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.000119	0.0029	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.000119	0.0029	CbGpPWpGaD
Vidarabine—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000119	0.00136	CcSEcCtD
Vidarabine—Vision blurred—Methotrexate—rheumatoid arthritis	0.000119	0.00136	CcSEcCtD
Vidarabine—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000118	0.00136	CcSEcCtD
Vidarabine—Vomiting—Cyclosporine—rheumatoid arthritis	0.000118	0.00135	CcSEcCtD
Vidarabine—ADK—Metabolism—B3GNT2—rheumatoid arthritis	0.000118	0.00288	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ACP5—rheumatoid arthritis	0.000118	0.00288	CbGpPWpGaD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.000118	0.00288	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CD28—rheumatoid arthritis	0.000118	0.00287	CbGpPWpGaD
Vidarabine—Rash—Cyclosporine—rheumatoid arthritis	0.000117	0.00134	CcSEcCtD
Vidarabine—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000117	0.00134	CcSEcCtD
Vidarabine—Headache—Cyclosporine—rheumatoid arthritis	0.000116	0.00133	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.000116	0.00283	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.000116	0.00283	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ACAN—rheumatoid arthritis	0.000116	0.00282	CbGpPWpGaD
Vidarabine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000115	0.00131	CcSEcCtD
Vidarabine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000114	0.00131	CcSEcCtD
Vidarabine—ADORA2A—G alpha (s) signalling events—POMC—rheumatoid arthritis	0.000114	0.00277	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.000113	0.00276	CbGpPWpGaD
Vidarabine—Urticaria—Dexamethasone—rheumatoid arthritis	0.000112	0.00128	CcSEcCtD
Vidarabine—Urticaria—Betamethasone—rheumatoid arthritis	0.000112	0.00128	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000112	0.00128	CcSEcCtD
Vidarabine—Dizziness—Prednisolone—rheumatoid arthritis	0.000112	0.00128	CcSEcCtD
Vidarabine—Asthenia—Triamcinolone—rheumatoid arthritis	0.000112	0.00128	CcSEcCtD
Vidarabine—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000111	0.00127	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.000111	0.0027	CbGpPWpGaD
Vidarabine—Nausea—Cyclosporine—rheumatoid arthritis	0.00011	0.00126	CcSEcCtD
Vidarabine—Paraesthesia—Prednisone—rheumatoid arthritis	0.00011	0.00126	CcSEcCtD
Vidarabine—Cough—Methotrexate—rheumatoid arthritis	0.00011	0.00126	CcSEcCtD
Vidarabine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000109	0.00125	CcSEcCtD
Vidarabine—Convulsion—Methotrexate—rheumatoid arthritis	0.000109	0.00125	CcSEcCtD
Vidarabine—ADA—Metabolism—SLC25A12—rheumatoid arthritis	0.000109	0.00265	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—ADRBK1—rheumatoid arthritis	0.000107	0.00262	CbGpPWpGaD
Vidarabine—Chest pain—Methotrexate—rheumatoid arthritis	0.000107	0.00123	CcSEcCtD
Vidarabine—Rash—Prednisolone—rheumatoid arthritis	0.000107	0.00122	CcSEcCtD
Vidarabine—Dermatitis—Prednisolone—rheumatoid arthritis	0.000106	0.00122	CcSEcCtD
Vidarabine—ADK—Metabolism—BGN—rheumatoid arthritis	0.000106	0.00259	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GC—rheumatoid arthritis	0.000106	0.00258	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGES—rheumatoid arthritis	0.000106	0.00258	CbGpPWpGaD
Vidarabine—Headache—Prednisolone—rheumatoid arthritis	0.000106	0.00121	CcSEcCtD
Vidarabine—Discomfort—Methotrexate—rheumatoid arthritis	0.000106	0.00121	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CCL21—rheumatoid arthritis	0.000106	0.00257	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—C5—rheumatoid arthritis	0.000105	0.00257	CbGpPWpGaD
Vidarabine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000105	0.0012	CcSEcCtD
Vidarabine—Rash—Hydrocortisone—rheumatoid arthritis	0.000104	0.00119	CcSEcCtD
Vidarabine—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000104	0.00119	CcSEcCtD
Vidarabine—Headache—Hydrocortisone—rheumatoid arthritis	0.000103	0.00118	CcSEcCtD
Vidarabine—Dizziness—Triamcinolone—rheumatoid arthritis	0.000103	0.00118	CcSEcCtD
Vidarabine—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000103	0.00118	CcSEcCtD
Vidarabine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000103	0.00117	CcSEcCtD
Vidarabine—Asthenia—Dexamethasone—rheumatoid arthritis	0.000101	0.00116	CcSEcCtD
Vidarabine—Asthenia—Betamethasone—rheumatoid arthritis	0.000101	0.00116	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.000101	0.00246	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.000101	0.00246	CbGpPWpGaD
Vidarabine—Nausea—Prednisolone—rheumatoid arthritis	0.0001	0.00115	CcSEcCtD
Vidarabine—Hyperhidrosis—Methotrexate—rheumatoid arthritis	9.92e-05	0.00114	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCR6—rheumatoid arthritis	9.9e-05	0.00241	CbGpPWpGaD
Vidarabine—Vomiting—Triamcinolone—rheumatoid arthritis	9.88e-05	0.00113	CcSEcCtD
Vidarabine—Vomiting—Methylprednisolone—rheumatoid arthritis	9.86e-05	0.00113	CcSEcCtD
Vidarabine—ADA—Metabolism—PLB1—rheumatoid arthritis	9.84e-05	0.0024	CbGpPWpGaD
Vidarabine—Nausea—Hydrocortisone—rheumatoid arthritis	9.8e-05	0.00112	CcSEcCtD
Vidarabine—Rash—Triamcinolone—rheumatoid arthritis	9.8e-05	0.00112	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—FAS—rheumatoid arthritis	9.79e-05	0.00239	CbGpPWpGaD
Vidarabine—Dermatitis—Triamcinolone—rheumatoid arthritis	9.79e-05	0.00112	CcSEcCtD
Vidarabine—ADK—Metabolism—ALOX5—rheumatoid arthritis	9.78e-05	0.00238	CbGpPWpGaD
Vidarabine—Rash—Methylprednisolone—rheumatoid arthritis	9.78e-05	0.00112	CcSEcCtD
Vidarabine—Dermatitis—Methylprednisolone—rheumatoid arthritis	9.77e-05	0.00112	CcSEcCtD
Vidarabine—Urticaria—Prednisone—rheumatoid arthritis	9.76e-05	0.00112	CcSEcCtD
Vidarabine—Headache—Triamcinolone—rheumatoid arthritis	9.74e-05	0.00112	CcSEcCtD
Vidarabine—Headache—Methylprednisolone—rheumatoid arthritis	9.71e-05	0.00111	CcSEcCtD
Vidarabine—Hypotension—Methotrexate—rheumatoid arthritis	9.59e-05	0.0011	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	9.35e-05	0.00107	CcSEcCtD
Vidarabine—Dizziness—Betamethasone—rheumatoid arthritis	9.32e-05	0.00107	CcSEcCtD
Vidarabine—Dizziness—Dexamethasone—rheumatoid arthritis	9.32e-05	0.00107	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—PDE2A—rheumatoid arthritis	9.24e-05	0.00225	CbGpPWpGaD
Vidarabine—Nausea—Triamcinolone—rheumatoid arthritis	9.23e-05	0.00106	CcSEcCtD
Vidarabine—Paraesthesia—Methotrexate—rheumatoid arthritis	9.22e-05	0.00106	CcSEcCtD
Vidarabine—Nausea—Methylprednisolone—rheumatoid arthritis	9.21e-05	0.00105	CcSEcCtD
Vidarabine—Dyspnoea—Methotrexate—rheumatoid arthritis	9.15e-05	0.00105	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—MAPK8—rheumatoid arthritis	9.15e-05	0.00223	CbGpPWpGaD
Vidarabine—Somnolence—Methotrexate—rheumatoid arthritis	9.12e-05	0.00105	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL3—rheumatoid arthritis	9.06e-05	0.00221	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL2—rheumatoid arthritis	9.06e-05	0.00221	CbGpPWpGaD
Vidarabine—Hypersensitivity—Prednisone—rheumatoid arthritis	9.05e-05	0.00104	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—LEP—rheumatoid arthritis	8.99e-05	0.00219	CbGpPWpGaD
Vidarabine—Vomiting—Dexamethasone—rheumatoid arthritis	8.97e-05	0.00103	CcSEcCtD
Vidarabine—Vomiting—Betamethasone—rheumatoid arthritis	8.97e-05	0.00103	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	8.94e-05	0.00218	CbGpPWpGaD
Vidarabine—Rash—Betamethasone—rheumatoid arthritis	8.89e-05	0.00102	CcSEcCtD
Vidarabine—Rash—Dexamethasone—rheumatoid arthritis	8.89e-05	0.00102	CcSEcCtD
Vidarabine—Dermatitis—Dexamethasone—rheumatoid arthritis	8.88e-05	0.00102	CcSEcCtD
Vidarabine—Dermatitis—Betamethasone—rheumatoid arthritis	8.88e-05	0.00102	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—SAA1—rheumatoid arthritis	8.86e-05	0.00216	CbGpPWpGaD
Vidarabine—Headache—Betamethasone—rheumatoid arthritis	8.83e-05	0.00101	CcSEcCtD
Vidarabine—Headache—Dexamethasone—rheumatoid arthritis	8.83e-05	0.00101	CcSEcCtD
Vidarabine—Asthenia—Prednisone—rheumatoid arthritis	8.81e-05	0.00101	CcSEcCtD
Vidarabine—Pain—Methotrexate—rheumatoid arthritis	8.78e-05	0.00101	CcSEcCtD
Vidarabine—ADA—Metabolism—MED1—rheumatoid arthritis	8.63e-05	0.0021	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PDE2A—rheumatoid arthritis	8.39e-05	0.00204	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NOS2—rheumatoid arthritis	8.38e-05	0.00204	CbGpPWpGaD
Vidarabine—Nausea—Betamethasone—rheumatoid arthritis	8.38e-05	0.000959	CcSEcCtD
Vidarabine—Nausea—Dexamethasone—rheumatoid arthritis	8.38e-05	0.000959	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6ST—rheumatoid arthritis	8.28e-05	0.00202	CbGpPWpGaD
Vidarabine—Urticaria—Methotrexate—rheumatoid arthritis	8.15e-05	0.000934	CcSEcCtD
Vidarabine—Dizziness—Prednisone—rheumatoid arthritis	8.12e-05	0.00093	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	8.09e-05	0.00197	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ACP5—rheumatoid arthritis	8.03e-05	0.00195	CbGpPWpGaD
Vidarabine—ADA—Metabolism—B3GNT2—rheumatoid arthritis	8.03e-05	0.00195	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ENO1—rheumatoid arthritis	7.97e-05	0.00194	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD80—rheumatoid arthritis	7.97e-05	0.00194	CbGpPWpGaD
Vidarabine—Vomiting—Prednisone—rheumatoid arthritis	7.81e-05	0.000894	CcSEcCtD
Vidarabine—Rash—Prednisone—rheumatoid arthritis	7.74e-05	0.000887	CcSEcCtD
Vidarabine—Dermatitis—Prednisone—rheumatoid arthritis	7.74e-05	0.000886	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—BDKRB2—rheumatoid arthritis	7.7e-05	0.00188	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL12—rheumatoid arthritis	7.7e-05	0.00188	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	7.69e-05	0.00187	CbGpPWpGaD
Vidarabine—Headache—Prednisone—rheumatoid arthritis	7.69e-05	0.000881	CcSEcCtD
Vidarabine—Hypersensitivity—Methotrexate—rheumatoid arthritis	7.56e-05	0.000866	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6R—rheumatoid arthritis	7.39e-05	0.0018	CbGpPWpGaD
Vidarabine—Asthenia—Methotrexate—rheumatoid arthritis	7.36e-05	0.000843	CcSEcCtD
Vidarabine—Nausea—Prednisone—rheumatoid arthritis	7.29e-05	0.000835	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—MMP1—rheumatoid arthritis	7.29e-05	0.00178	CbGpPWpGaD
Vidarabine—ADA—Metabolism—BGN—rheumatoid arthritis	7.23e-05	0.00176	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL13—rheumatoid arthritis	7.18e-05	0.00175	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—LEP—rheumatoid arthritis	7.05e-05	0.00172	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	6.93e-05	0.00169	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL10—rheumatoid arthritis	6.81e-05	0.00166	CbGpPWpGaD
Vidarabine—Dizziness—Methotrexate—rheumatoid arthritis	6.79e-05	0.000777	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	6.77e-05	0.00165	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—rheumatoid arthritis	6.73e-05	0.00164	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX5—rheumatoid arthritis	6.65e-05	0.00162	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL6—rheumatoid arthritis	6.54e-05	0.00159	CbGpPWpGaD
Vidarabine—Vomiting—Methotrexate—rheumatoid arthritis	6.53e-05	0.000747	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL13—rheumatoid arthritis	6.52e-05	0.00159	CbGpPWpGaD
Vidarabine—Rash—Methotrexate—rheumatoid arthritis	6.47e-05	0.000741	CcSEcCtD
Vidarabine—Dermatitis—Methotrexate—rheumatoid arthritis	6.47e-05	0.00074	CcSEcCtD
Vidarabine—Headache—Methotrexate—rheumatoid arthritis	6.43e-05	0.000736	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—TP53—rheumatoid arthritis	6.38e-05	0.00155	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6ST—rheumatoid arthritis	6.37e-05	0.00155	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL21—rheumatoid arthritis	6.24e-05	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SYVN1—rheumatoid arthritis	6.24e-05	0.00152	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2RB—rheumatoid arthritis	6.16e-05	0.0015	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—CD80—rheumatoid arthritis	6.13e-05	0.00149	CbGpPWpGaD
Vidarabine—Nausea—Methotrexate—rheumatoid arthritis	6.1e-05	0.000698	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—POMC—rheumatoid arthritis	6.06e-05	0.00148	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TAGAP—rheumatoid arthritis	5.98e-05	0.00146	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C5—rheumatoid arthritis	5.95e-05	0.00145	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CCL2—rheumatoid arthritis	5.93e-05	0.00144	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL5—rheumatoid arthritis	5.86e-05	0.00143	CbGpPWpGaD
Vidarabine—ADA—Circadian rythm related genes—IL6—rheumatoid arthritis	5.84e-05	0.00142	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CX3CR1—rheumatoid arthritis	5.82e-05	0.00142	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAT—rheumatoid arthritis	5.74e-05	0.0014	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6R—rheumatoid arthritis	5.68e-05	0.00138	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—MMP2—rheumatoid arthritis	5.64e-05	0.00137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2RB—rheumatoid arthritis	5.6e-05	0.00136	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR6—rheumatoid arthritis	5.6e-05	0.00136	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ENO1—rheumatoid arthritis	5.42e-05	0.00132	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	5.42e-05	0.00132	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C5—rheumatoid arthritis	5.41e-05	0.00132	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	5.3e-05	0.00129	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCR5—rheumatoid arthritis	5.28e-05	0.00129	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—MAPK8—rheumatoid arthritis	5.25e-05	0.00128	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—TYK2—rheumatoid arthritis	5.17e-05	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—C3—rheumatoid arthritis	5.16e-05	0.00126	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL2—rheumatoid arthritis	5.12e-05	0.00125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR6—rheumatoid arthritis	5.08e-05	0.00124	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—SAA1—rheumatoid arthritis	5.01e-05	0.00122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDE2A—rheumatoid arthritis	4.96e-05	0.00121	CbGpPWpGaD
Vidarabine—ADK—Metabolism—MTHFR—rheumatoid arthritis	4.79e-05	0.00117	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLB1—rheumatoid arthritis	4.73e-05	0.00115	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—rheumatoid arthritis	4.69e-05	0.00114	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL2—rheumatoid arthritis	4.65e-05	0.00113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL3—rheumatoid arthritis	4.65e-05	0.00113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—SAA1—rheumatoid arthritis	4.55e-05	0.00111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RBPJ—rheumatoid arthritis	4.36e-05	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	4.35e-05	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL12—rheumatoid arthritis	4.35e-05	0.00106	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	4.3e-05	0.00105	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	4.19e-05	0.00102	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—POMC—rheumatoid arthritis	4.13e-05	0.001	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	4.06e-05	0.000989	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CCL2—rheumatoid arthritis	4.04e-05	0.000983	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—NFKB1—rheumatoid arthritis	4.03e-05	0.000982	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	3.97e-05	0.000967	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—MAPK8—rheumatoid arthritis	3.96e-05	0.000965	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL12—rheumatoid arthritis	3.95e-05	0.000963	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—BDKRB2—rheumatoid arthritis	3.95e-05	0.000963	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRBK1—rheumatoid arthritis	3.91e-05	0.000952	CbGpPWpGaD
Vidarabine—ADA—Metabolism—CAT—rheumatoid arthritis	3.9e-05	0.00095	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL13—rheumatoid arthritis	3.85e-05	0.000939	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL10—rheumatoid arthritis	3.85e-05	0.000937	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—rheumatoid arthritis	3.83e-05	0.000933	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	3.69e-05	0.000898	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—TP53—rheumatoid arthritis	3.67e-05	0.000893	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	3.61e-05	0.000879	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL10—rheumatoid arthritis	3.49e-05	0.000851	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—rheumatoid arthritis	3.49e-05	0.000851	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IRAK1—rheumatoid arthritis	3.47e-05	0.000845	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TLE3—rheumatoid arthritis	3.47e-05	0.000845	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CX3CR1—rheumatoid arthritis	3.44e-05	0.000837	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—rheumatoid arthritis	3.36e-05	0.000817	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—rheumatoid arthritis	3.34e-05	0.000814	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL5—rheumatoid arthritis	3.31e-05	0.000807	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2RB—rheumatoid arthritis	3.31e-05	0.000805	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—rheumatoid arthritis	3.29e-05	0.000801	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CSF2—rheumatoid arthritis	3.26e-05	0.000794	CbGpPWpGaD
Vidarabine—ADA—Metabolism—MTHFR—rheumatoid arthritis	3.26e-05	0.000793	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C5—rheumatoid arthritis	3.19e-05	0.000778	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—rheumatoid arthritis	3.19e-05	0.000777	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—MMP3—rheumatoid arthritis	3.19e-05	0.000776	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NFATC1—rheumatoid arthritis	3.14e-05	0.000765	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTGS2—rheumatoid arthritis	3.06e-05	0.000744	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL5—rheumatoid arthritis	3.01e-05	0.000732	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR6—rheumatoid arthritis	3e-05	0.000731	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR5—rheumatoid arthritis	2.98e-05	0.000727	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CSF2—rheumatoid arthritis	2.96e-05	0.000721	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	2.94e-05	0.000716	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCF2—rheumatoid arthritis	2.92e-05	0.000711	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C3—rheumatoid arthritis	2.92e-05	0.00071	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SH2B3—rheumatoid arthritis	2.85e-05	0.000693	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TRAF6—rheumatoid arthritis	2.85e-05	0.000693	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—GZMB—rheumatoid arthritis	2.83e-05	0.000689	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL3—rheumatoid arthritis	2.75e-05	0.000669	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL2—rheumatoid arthritis	2.75e-05	0.000669	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR5—rheumatoid arthritis	2.71e-05	0.00066	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SAA1—rheumatoid arthritis	2.69e-05	0.000654	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	2.67e-05	0.00065	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C3—rheumatoid arthritis	2.65e-05	0.000645	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NCF1—rheumatoid arthritis	2.63e-05	0.000641	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—rheumatoid arthritis	2.6e-05	0.000634	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—rheumatoid arthritis	2.53e-05	0.000616	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CD28—rheumatoid arthritis	2.53e-05	0.000616	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.38e-05	0.00058	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—rheumatoid arthritis	2.37e-05	0.000578	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL12—rheumatoid arthritis	2.34e-05	0.000569	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.34e-05	0.000569	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—rheumatoid arthritis	2.33e-05	0.000568	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	2.32e-05	0.000564	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.31e-05	0.000562	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—rheumatoid arthritis	2.27e-05	0.000553	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.18e-05	0.00053	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SYK—rheumatoid arthritis	2.17e-05	0.000529	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.13e-05	0.000519	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—rheumatoid arthritis	2.12e-05	0.000516	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT1—rheumatoid arthritis	2.09e-05	0.00051	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—rheumatoid arthritis	2.08e-05	0.000506	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	2.07e-05	0.000505	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	2.07e-05	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	2.06e-05	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP3—rheumatoid arthritis	1.88e-05	0.000458	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	1.88e-05	0.000458	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTK2—rheumatoid arthritis	1.81e-05	0.000441	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.8e-05	0.000439	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL5—rheumatoid arthritis	1.78e-05	0.000433	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CSF2—rheumatoid arthritis	1.75e-05	0.000426	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	1.72e-05	0.00042	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.65e-05	0.000401	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.64e-05	0.000399	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.6e-05	0.00039	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.58e-05	0.000384	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.57e-05	0.000381	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C3—rheumatoid arthritis	1.56e-05	0.000381	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—rheumatoid arthritis	1.46e-05	0.000355	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FN1—rheumatoid arthritis	1.37e-05	0.000334	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.37e-05	0.000333	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CD80—rheumatoid arthritis	1.32e-05	0.000321	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—rheumatoid arthritis	1.25e-05	0.000305	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.22e-05	0.000298	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.22e-05	0.000297	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.11e-05	0.000271	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.09e-05	0.000266	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	9.68e-06	0.000236	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2—rheumatoid arthritis	9.25e-06	0.000225	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—rheumatoid arthritis	9.2e-06	0.000224	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—rheumatoid arthritis	8.75e-06	0.000213	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	8.66e-06	0.000211	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	8.51e-06	0.000207	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	7.86e-06	0.000191	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.21e-06	0.000176	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TP53—rheumatoid arthritis	5.94e-06	0.000145	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—rheumatoid arthritis	5.44e-06	0.000132	CbGpPWpGaD
